SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Involving Possible Securities Fraud Violations by ProNAi Therapeutics Inc. and Certain Officers and Directors

NEW YORK--()--Levi & Korsinsky, LLP announces that it has commenced an investigation of ProNAi Therapeutics Inc. (“ProNAi” or the “Company”) (NASDAQ:DNAI) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/pronai-dnai

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq., 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com

Release Summary

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Involving Possible Securities Fraud Violations by ProNAi Therapeutics Inc. and Certain Officers and Directors -- DNAI

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq., 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com